Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

nti-tumour potential and selectivity of caffeic acid phenethyl ester in osteosarcoma cell

Texto completo
Autor(es):
Pagnan, Ana Ligia [1] ; Pessoa, Adriano Souza [1] ; Tokuhara, Cintia Kazuko [1] ; Fakhoury, Vanessa Svizzero [1] ; Oliveira, Gabriela Silva Neubern [1] ; Sanches, Mariana Liessa Rovis [1] ; Inacio, Kelly Karina [1] ; Ximenes, Valdecir Farias [2] ; Oliveira, Rodrigo Cardoso [1]
Número total de Autores: 9
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP - Brazil
[2] UNESP Sao Paulo State Univ, Fac Sci, Dept Chem, Bauru, SP - Brazil
Número total de Afiliações: 2
Tipo de documento: Artigo Científico
Fonte: TISSUE & CELL; v. 74, FEB 2022.
Citações Web of Science: 0
Resumo

Osteosarcoma is the most common type of bone cancer, and metastasis is widespread decreasing the survival rate. The search for new therapeutic strategies has increased for phytochemicals due to their potential as antioxidants and anticancer properties. Thus, we evaluated the caffeic acid phenethyl ester (CAPE) and caffeic acid's (CA) anticancer properties on UMR-106 murine osteosarcoma cells. The IC25 and IC50 were 1.3 and 2.7 mu M for CAPE and 91.0 and 120.0 mu M for CA, respectively. This study shows the potential anticancer properties of CAPE and highlights how a phenethyl ester component addition can improve the pharmacological potency in relation to its precursor CA. Our results showed that CAPE was more efficient and selective in reducing the viability of tumor cells compared to the control osteoblasts (MC3T3-E1) (p < 0.05). In addition, CAPE was 44-fold (IC25) and 70-fold (IC50) more cytotoxic than CA. CAPE also decreased ROS generation and cell migration. In summary, CAPE was more selective for tumor cells, preserving normal ones, suggesting its potential role as an anticancer drug. (AU)

Processo FAPESP: 18/10321-2 - Efeito do ácido cafeico e o éster fenetil do ácido cafeico em células de osteossarcoma murinos: regulação do complexo NADPH oxidase
Beneficiário:Ana Lígia Pagnan
Modalidade de apoio: Bolsas no Brasil - Mestrado